Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID

Author:

Calderón-Parra JorgeORCID,Muiño-Miguez Antonio,Bendala-Estrada Alejandro D.ORCID,Ramos-Martínez Antonio,Muñez-Rubio Elena,Fernández Carracedo Eduardo,Tejada Montes Javier,Rubio-Rivas Manuel,Arnalich-Fernandez Francisco,Beato Pérez Jose Luis,García Bruñén Jose Miguel,del Corral Beamonte Esther,Pesqueira Fontan Paula Maria,Carmona Maria del Mar,Fernández-Madera Martínez Rosa,González García Andrés,Salazar Mosteiro Cristina,Tuñón de Almeida Carlota,González Moraleja Julio,Deodati Francesco,Martín Escalante María Dolores,Asensio Tomás María Luisa,Gómez Huelgas Ricardo,Casas Rojo José Manuel,Millán Núñez-Cortés Jesús,

Abstract

Background Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-infections are rare. This can lead to increased complications, including antibacterial resistance. We aim to analyze risk factors for inappropriate antibiotic prescription in these patients and describe possible complications arising from their use. Methods The SEMI-COVID-19 Registry is a multicenter, retrospective patient cohort. Patients with antibiotic were divided into two groups according to appropriate or inappropriate prescription, depending on whether the patient fulfill any criteria for its use. Comparison was made by means of multilevel logistic regression analysis. Possible complications of antibiotic use were also identified. Results Out of 13,932 patients, 3047 (21.6%) were prescribed no antibiotics, 6116 (43.9%) were appropriately prescribed antibiotics, and 4769 (34.2%) were inappropriately prescribed antibiotics. The following were independent factors of inappropriate prescription: February-March 2020 admission (OR 1.54, 95%CI 1.18–2.00), age (OR 0.98, 95%CI 0.97–0.99), absence of comorbidity (OR 1.43, 95%CI 1.05–1.94), dry cough (OR 2.51, 95%CI 1.94–3.26), fever (OR 1.33, 95%CI 1.13–1.56), dyspnea (OR 1.31, 95%CI 1.04–1.69), flu-like symptoms (OR 2.70, 95%CI 1.75–4.17), and elevated C-reactive protein levels (OR 1.01 for each mg/L increase, 95% CI 1.00–1.01). Adverse drug reactions were more frequent in patients who received ANTIBIOTIC (4.9% vs 2.7%, p < .001). Conclusion The inappropriate use of antibiotics was very frequent in COVID-19 patients and entailed an increased risk of adverse reactions. It is crucial to define criteria for their use in these patients. Knowledge of the factors associated with inappropriate prescribing can be helpful.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. An interactive web-based dashboard to track COVID-19 in real time;E Dong;Lancet Infect Dis,2020

2. Antimicrobial use, drug-resistant infections and COVID-19;TM Rawson;Nat Rev Microbiol,2020

3. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis;BJ Langford;Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis,2021

4. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing;TM Rawson;Clin Infect Dis,2020

5. Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?;CJ Clancy;Clin Infect Dis Off Publ Infect Dis Soc Am,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3